HomeBICO • STO
BICO Group AB
kr 44.12
Sep 27, 6:00:00 PM GMT+2 · SEK · STO · Disclaimer
StockSE listed security
Previous close
kr 42.92
Day range
kr 42.92 - kr 45.30
Year range
kr 23.38 - kr 72.30
Market cap
3.85B SEK
Avg Volume
294.70K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK)Jun 2024Y/Y change
Revenue
534.00M-0.56%
Operating expense
324.90M86.51%
Net income
-77.90M81.64%
Net profit margin
-14.5981.53%
Earnings per share
EBITDA
35.50M-93.03%
Effective tax rate
8.49%
Total assets
Total liabilities
(SEK)Jun 2024Y/Y change
Cash and short-term investments
687.60M-0.45%
Total assets
5.70B-37.50%
Total liabilities
2.72B-11.43%
Total equity
2.97B
Shares outstanding
70.57M
Price to book
1.03
Return on assets
-2.15%
Return on capital
-2.50%
Net change in cash
(SEK)Jun 2024Y/Y change
Net income
-77.90M81.64%
Cash from operations
-50.90M-6.71%
Cash from investing
-22.60M80.11%
Cash from financing
-27.80M-424.53%
Net change in cash
-108.10M35.88%
Free cash flow
-91.89M-126.44%
About
Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics. Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet. The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Founded
Jan 27, 2016
Website
Employees
832
Search
Clear search
Close search
Google apps
Main menu